BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10323381)

  • 1. Measurements of insulin-mediated glucose disposal are stable over time.
    Facchini F; Humphreys MH; Jeppesen J; Reaven GM
    J Clin Endocrinol Metab; 1999 May; 84(5):1567-9. PubMed ID: 10323381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers.
    Abbasi F; McLaughlin T; Lamendola C; Reaven GM
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1251-4. PubMed ID: 10720071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to insulin-mediated glucose disposal in patients with noninsulin-dependent diabetes mellitus in the absence of obesity or microalbuminuria--a Clinical Research Center study.
    Sheu W; Jeng CY; Fuh M; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1156-9. PubMed ID: 8772592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between insulin-mediated glucose disposal by muscle and adipose tissue lipolysis in healthy volunteers.
    Pei D; Chen YD; Hollenbeck CB; Bhargava R; Reaven GM
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3368-72. PubMed ID: 7593453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women.
    McLaughlin T; Abbasi F; Carantoni M; Schaaf P; Reaven G
    J Clin Endocrinol Metab; 1999 Feb; 84(2):578-81. PubMed ID: 10022419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to insulin-stimulated-glucose uptake in patients with hypertension.
    Shen DC; Shieh SM; Fuh MM; Wu DA; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1988 Mar; 66(3):580-3. PubMed ID: 3350907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.
    Evans DJ; Murray R; Kissebah AH
    J Clin Invest; 1984 Oct; 74(4):1515-25. PubMed ID: 6148358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease.
    Yip J; Facchini FS; Reaven GM
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2773-6. PubMed ID: 9709945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
    Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
    J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects.
    Rosolova H; Mayer O; Reaven G
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3783-5. PubMed ID: 9360541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.
    Yeni-Komshian H; Carantoni M; Abbasi F; Reaven GM
    Diabetes Care; 2000 Feb; 23(2):171-5. PubMed ID: 10868826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers.
    Wang PW; Abbasi F; Carantoni M; Chen YD; Azhar S; Reaven GM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3221-4. PubMed ID: 9329342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glipizide treatment on response to an infused glucose load in patients with NIDDM.
    Sheu WH; Jeng CY; Fuh MM; Chen YD; Reaven GM
    Diabetes Care; 1995 Dec; 18(12):1582-7. PubMed ID: 8722055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic abnormalities following heart transplantation in patients with idiopathic cardiomyopathy.
    Sheu WH; Wei J; Jeng CY; Fuh MM; Chen YD
    Horm Metab Res; 1995 Oct; 27(10):469-72. PubMed ID: 8575727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis.
    Greco AV; Rebuzzi AG; Altomonte L; Manna R; Bertoli A; Ghirlanda G
    Horm Metab Res; 1979 Oct; 11(10):547-9. PubMed ID: 521009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How insulin resistant are patients with noninsulin-dependent diabetes mellitus?
    Reaven GM; Chen YD; Donner CC; Fraze E; Hollenbeck CB
    J Clin Endocrinol Metab; 1985 Jul; 61(1):32-6. PubMed ID: 3889039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of noninsulin-mediated glucose disposal in the elderly.
    Meneilly GS; Elahi D; Minaker KL; Sclater AL; Rowe JW
    J Clin Endocrinol Metab; 1989 Mar; 68(3):566-71. PubMed ID: 2563735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of difference in glucose infusion rate on quantification of hepatic glucose production.
    Sheu WH; Hollenbeck CB; Wu MS; Jaspan JB; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1990 May; 70(5):1354-60. PubMed ID: 1970829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.